| Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664) |
|---|
| 06/19/2008 | WO2008073390A2 Preparation of 3,4-dihydroisoquinolines from an acid and an amine |
| 06/19/2008 | WO2008071736A1 Benzamide derivatives as ep4 receptor agonists |
| 06/19/2008 | US20080146778 Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same |
| 06/19/2008 | US20080145320 Antimicrobial compositions |
| 06/19/2008 | CA2674099A1 Preparation of amides from an acid and amine for intermediates in the synthesis of morphinans |
| 06/19/2008 | CA2672631A1 Benzamide derivatives as ep4 receptor agonists |
| 06/19/2008 | CA2670834A1 Preparation of 3,4-dihydroisoquinolines from an acid and an amine |
| 06/18/2008 | EP1931327A2 Cyclopropyl compounds and compositions for delivering active agents |
| 06/18/2008 | EP1931220A1 Flavour modulating substances |
| 06/18/2008 | EP1513803B1 Ligands that are inhibitors of the rar receptors |
| 06/18/2008 | CN101203483A N-substituted phenylacetamide derivative and pharmaceutical composition comprising the same |
| 06/18/2008 | CN101203278A UV protection |
| 06/18/2008 | CN100395272C Photoactive materials |
| 06/17/2008 | US7388118 Amine 1,2- and 1,3-diol compounds |
| 06/12/2008 | WO2008069611A1 N-phenylamide derivative, process for the preparation thereof, and composition for preventing or treating ischemic diseases comprising same |
| 06/12/2008 | WO2008015584A3 Improved process for synthesizing desvenlafaxine free base and salts or solvates thereof |
| 06/12/2008 | US20080139811 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection |
| 06/12/2008 | US20080139636 Adamantane derivatives |
| 06/12/2008 | US20080139630 Tissue-selective androgen receptor modulators (SARMs); male hypogonadism, prostate cancer, benign prostate hyperplasia, sarcopenia, rheumatoid arthritis and osteoarthritis; N-((5-cyclopropyl-2-fluoropyridin-3-yl)methyl)-2-phenylbutanamide for example |
| 06/11/2008 | EP1169393B1 Acetoacetylarylide suspensions in pigment applications |
| 06/11/2008 | CN101198584A Benzamide derivatives and uses related thereto |
| 06/11/2008 | CN101195582A Cinnamic amide derivant |
| 06/11/2008 | CN101195569A Method for producing (S) or (R)-6-hydroxyl-8-alkoxide octylic acid, its ester, salt, amide |
| 06/11/2008 | CN101195568A (S) or (R)-6-hydroxyl-8-alkoxide octylic acid, its ester, salt, amide, preparation method and application thereof |
| 06/10/2008 | US7384982 e.g., disodium N-(5-chlorosalicyloyl)-8-amN-(10-[2-hydroxybenzoyl]amino)decanoate and disodium N-(10-[2-hydroxybenzoyl]amino)decanoate |
| 06/10/2008 | US7384979 Substituted amino acids as erythropoietin mimetics |
| 06/05/2008 | WO2008064432A1 Polycyclic molecular compounds |
| 06/05/2008 | WO2006138508B1 Benzamide derivatives and uses related thereto |
| 06/05/2008 | US20080132711 High Molecular Weight Polyamine Salts as Clay Stabilizing Agents |
| 06/05/2008 | US20080132706 Compounds as PDE IV and TNF Inhibitors |
| 06/05/2008 | US20080132578 venlafaxine metabolites used for treating and preventing psychological disorders, Parkinson's disease, epilepsy, obesity, incontinence or Alzheimer's disease; side effect reduction |
| 06/05/2008 | US20080132574 Leukotriene B4 receptor binding activity; treatment of skin disease such as psoriasis, eczema, skin cancer, keratosis, dyspigmentation or psilosis |
| 06/05/2008 | US20080132573 ricinoleic acid derivatives; transient receptor potential vanilloid (cannabinoid receptor) agonist; neuroprotective effect against glutamate excitotoxicity, antiemetic; urinary incontinence, for the relief of neuropathic pain, intestinal inflammatory disorders |
| 06/05/2008 | US20080132570 Levodopa prodrugs, and compositions and uses thereof |
| 06/05/2008 | US20080132544 Peroxisome Proliferator-Activated Receptor Ligand |
| 06/05/2008 | US20080132480 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease |
| 06/05/2008 | US20080132459 Inhibitors of Histone Deacetylase |
| 06/04/2008 | EP1927587A2 Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof |
| 06/04/2008 | EP1926703A1 Novel carboxylic acid derivatives |
| 06/04/2008 | CN101193880A Exo- and diastereo- selective syntheses of himbacine analogs |
| 06/04/2008 | CN101193853A Anthranilic acid derivatives |
| 06/03/2008 | US7381840 2-Hydroxy-1,2,3,4-tetrahydronaphthalenes substituted in the 8-position with a biphenylcarbonylamino-, biphenylcarbonylaminoalkyl-, biphenylaminocarbonylamino-, or biphenylaminocarbonylaminoalkyl- group; vanilloid receptor antagonists |
| 06/03/2008 | US7381750 Amino-phenoxymethyl-benzamide opioid receptor antagonists |
| 06/03/2008 | US7381719 To treat obesity and Related Diseases; oral bioavailablility, oral administration; inhibition of orexigenic effects; side effects reduction; weight loss while maintaining or minimizing the loss of lean muscle mass; 6-[4-(2-Benzylamino-ethyl)-phenoxy]-nicotinamide |
| 05/29/2008 | WO2008061822A1 Process for preparing carboxamides by hydrolysis of carboxylic acid nitriles in the presence of a catalyst comprising manganese dioxide |
| 05/29/2008 | US20080125601 Key steps in the synthesis are early introduction of the correct absolute stereochemistry at C-3 (R) and subsequent regioselective chain lengthening; Unlike the linear synthesis processes in the prior art, the use of the novel statin side chain building blocks allows a convergent synthesis |
| 05/29/2008 | US20080125491 screening for neuroprotectants such as -Isobutyryl-1,4-a-dimethyl-1,2,3,4,4a,9,10,10a-octahydro-phenanthrene-1-carboxylic acid amide, used for the prevention of neurodegenerative diseases and cardiovascular disorders |
| 05/29/2008 | US20080125465 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 05/29/2008 | CA2666397A1 Process for preparing carboxamides by hydrolysing carbonitriles in the presence of a catalyst comprising manganese dioxide |
| 05/28/2008 | EP1768954A4 2-methylpropanamides and their use as pharmaceuticals |
| 05/28/2008 | EP1322595B1 (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents |
| 05/28/2008 | EP0938584B1 Method of preparing (s) - or (r) -3,3,3-trifluoro-2-hydroxy-2- methylpropionic acid |
| 05/28/2008 | CN101186586A N,N'-difluorophenyl derivative of 4-methoxyl-1,3-phthalamide and use thereof |
| 05/28/2008 | CN101186584A Process for preparing carboxamides by hydrolysis of carboxylic acid nitriles in the presence of a catalyst comprising manganese dioxide |
| 05/28/2008 | CN100390135C Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 05/27/2008 | US7378448 Diphenylether amide derivatives as opioid receptor antagonists |
| 05/27/2008 | US7378446 1-((4,14-(Dioxo),5-(1-hydroxy,1,2-dicarboxyethyl)),3-azaoctadec-6-enyl-),4-(phenoxy)benzene derivatives and salts ; extremely potent replication inhibitory activity against the hepatitis C virus (HCV); chronic hepatitis, cirrhosis and liver cancer; mild cytotoxicity in vitro; prophylaxis; prodrugs |
| 05/27/2008 | US7378444 Antiinflammatory agents; cardiovascular disorders; vision disorders; skin disorders; central nervous system disorders; antiarthritic agents |
| 05/22/2008 | US20080119556 Geranly compounds |
| 05/22/2008 | US20080119526 Ep2 receptor agonists |
| 05/22/2008 | US20080119512 Carboxamide Derivatives as Therapeutic Agents |
| 05/21/2008 | EP1923473A1 Bis-diglycolamides (BISDGA) as new extractants for lanthanides [Ln(III)] and actinides [An(III)] from aqueous high-level wastes |
| 05/21/2008 | EP1923379A1 Process for preparing chlorinated carbonyl compounds in jet loop reactors |
| 05/21/2008 | EP1922926A1 Antimicrobial compounds |
| 05/21/2008 | EP1922301A1 Preparation of an atorvastatin intermediate |
| 05/21/2008 | EP1562595B1 Diaryl ethers as opioid receptor antagonists |
| 05/21/2008 | EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 05/21/2008 | CN101184726A 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
| 05/21/2008 | CN101184724A Method for producing acetoacetic acid arylamides |
| 05/21/2008 | CN101182299A Mydrial derivates,preparation method of mydrial derivates and cosmetics or skin medicinal composition |
| 05/20/2008 | US7375093 Nuclear receptor-based inducible gene expression system |
| 05/20/2008 | US7375088 culture product from a Streptomyces aizunensis strain; inhibitors of fungal cell growth and cancer cell growth; for lowering serum cholesterol and other steroids |
| 05/20/2008 | CA2453123C Intermediate for condensed benzazepine derivatives |
| 05/20/2008 | CA2395717C Fused imidazolium derivatives |
| 05/15/2008 | WO2008057862A2 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ϰB ACTIVITY AND USE THEREOF |
| 05/15/2008 | WO2008056207A1 Transdermal delivery systems of peptides and related compounds |
| 05/15/2008 | US20080114064 Tri(Hydroxymethyl)Methylamine Salt or an Ethanol Amine Salt of (2S)-2-Ethoxy-3-(4-PHENYL) Propanoic Acid |
| 05/15/2008 | US20080114062 N-(2-hydroxy-1-methyl-ethyl)-3-iodobenzamide; for the treatment of a muscular disorder, a gastrointestinal disorder, or for controlling spasticity or tremors; modulates cannabinoid receptors |
| 05/15/2008 | US20080113939 N-geranylgalacturonamide; anticarcinogenic, antitumor agent |
| 05/15/2008 | US20080112946 Catalytically active recombinant memapsin and methods of use thereof |
| 05/15/2008 | DE102006053500A1 Antimicrobial compounds for controlling selective microorganisms such as gram-positive bacteria, particularly coryneform bacteria, has general formula |
| 05/15/2008 | CA2668500A1 Transdermal delivery systems of peptides and related compounds |
| 05/14/2008 | EP1919857A2 Process for the synthesis of mandipropamid and derivatives thereof |
| 05/14/2008 | CN101180268A Novel haloalkoxy-substituted salicylic anilides |
| 05/14/2008 | CN101180266A Alpha ketoamide compounds as cysteine protease inhibitors |
| 05/14/2008 | CN101180260A Organic compounds |
| 05/14/2008 | CN101177404A Method for preparing high-purity p-chloro-m-nitroacetoacetanilide |
| 05/14/2008 | CN101177385A Aryl sulfonic acid amides and analogues as well as its purpose in curing neural degeneration disease |
| 05/14/2008 | CA2610613A1 Antimicrobial compositions |
| 05/13/2008 | US7371896 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 05/13/2008 | US7371766 Curcumin analogs with anti-tumor and anti-angiogenic properties |
| 05/08/2008 | WO2008053393A2 Rotary actuator |
| 05/08/2008 | WO2008053051A2 Panthenol esters of unsaturated carboxylic acids |
| 05/08/2008 | US20080108810 Prepared by reacting 2,3,4-trifluoronitrobenzene with an alkali metal aryloxide, contacting product with an alkali metal salt of a malonate diester to replace 4-fluoro group with malonate; optional further hydrolysis, reduction of the NO2 group, and decarboxylation; use in treatment of HIV |
| 05/08/2008 | US20080107709 Radio-opaque polymeric biomaterials |
| 05/07/2008 | EP1918272A1 Pharmaceutically active compounds and methods of use |
| 05/07/2008 | EP1918023A1 Process for producing catalyst for cyanhydrin hydration and product of the process |
| 05/07/2008 | EP1644318B1 Method for synthesizing ceramide-type compounds |
| 05/07/2008 | CN101172959A N,N*-2[fluoroform (oxygen) group] substituted phenyl derivant of 4-methoxy-1,3-benzene diamide and uses of the same |
| 05/07/2008 | CN101172958A N,N*-2(2substituted phenyl) derivant of - 4-methoxy-1,3-benzol diamide and use of the same |